Skip to content

Artificial Intelligence for Determination of Gastroscopy Surveillance Intervals

Development and Validation of Gastroscopy Surveillance Recommendations Based on Natural Language Processing for Patients With Gastric Cancer and Precancerous Diseases

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05631015
Enrollment
2000
Registered
2022-11-30
Start date
2012-01-01
Completion date
2023-12-31
Last updated
2022-11-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrophic Gastritis, Early Gastric Cancer, Gastric Cancer, Helicobacter Pylori Infection, High Grade Intraepithelial Neoplasia, Intestinal Metaplasia, Low Grade Intraepithelial Neoplasia

Brief summary

The purpose of this study is to develop and validate a clinical decision support system based on automated algorithms. This system can use natural language processing to extract data from patients' endoscopic reports and pathological reports, identify patients' disease types and grades, and generate guidelines based follow-up or treatment recommendations

Interventions

OTHERAI recongnize disease and generate recommendations

According the endoscopic reports and pathological reports, the decision support system recognise patients' disease types and grades, and generate guidelines based survilliance or treatment recommendations.

Sponsors

Xiuli Zuo
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years

Inclusion criteria

* Patients aged 18 - 80 years * Patients underwent endoscopic examination

Exclusion criteria

* Patients with the contraindications to endoscopic examination * Patients with imcomplete examination information * Patients undergo endoscopy for therapy * Patients have history of upper gastrointestinal surgery * Patients with duodenal or Laryngeal neoplasms * Patients with gastrointestinal submucosal tumor

Design outcomes

Primary

MeasureTime frameDescription
The diagnostic accuracy of gastric diseases with deep learning algorithm12 monthThe diagnostic accuracy of gastric diseases with deep learning algorithm
The accuracy of recommentions for different disease with deep learning algorithm12 monthThe accuracy of recommentions for different disease with deep learning algorithm

Secondary

MeasureTime frameDescription
The diagnostic positive predictive value of gastric diseases with deep learning algorithm12 monthThe diagnostic positive predictive valu of gastric diseases with deep learning algorithm
The diagnostic sensitivity of gastric diseases with deep learning algorithm12 monthThe diagnostic sensitivity of gastric diseases with deep learning algorithm
The F-score of gastric diseases with deep learning algorithm12 monthThe F-score of gastric diseases with deep learning algorithm
The diagnostic negative predictive value of gastric diseases with deep learning algorithm12 monthThe diagnostic negative predictive value of gastric diseases with deep learning algorithm
The diagnostic specificity of gastric diseases with deep learning algorithm12 monthThe diagnostic specificity of gastric diseases with deep learning algorithm

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026